Alphonse Galdes Biogen Inc. (BIIB) insider trading activity

BIIB Quotes by TradingView

Alphonse Galdes is EVP Pharmaceutical Oper & Tech of BIOGEN INC.. Currently has a direct ownership of 5,064 shares of BIIB, which is worth approximately $880,072. The most recent transaction as insider was on Jan 19, 2022, when has been sold 658 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.06K
0% 3M change
0% 12M change
Total Value Held $880,072

Alphonse Galdes Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 19 2022
BUY
Grant, award, or other acquisition
-
658 Added 11.5%
5,064 Common Stock
Feb 12 2021
SELL
Payment of exercise price or tax liability
$198,791 $278.03 p/Share
715 Reduced 14.25%
4,303 Common Stock
Feb 12 2021
BUY
Exercise of conversion of derivative security
-
1,573 Added 24.82%
4,765 Common Stock
Jan 27 2021
BUY
Grant, award, or other acquisition
-
818 Added 19.19%
3,445 Common Stock
AG

Alphonse Galdes

EVP Pharmaceutical Oper & Tech
Cambridge, MA

Track Institutional and Insider Activities on BIIB

Follow BIOGEN INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIIB shares.

Notify only if

Insider Trading

Get notified when an Biogen Inc. insider buys or sells BIIB shares.

Notify only if

News

Receive news related to BIOGEN INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on BIIB